http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1658309-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37f4922dfb7777b019e504b885211b8e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9c37762188a56acca3ecbc14acf8881b |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-006 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2840-20 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-463 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85 |
| filingDate | 2004-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2006-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_547b593b6c5d0952bc7d018d5a456e66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28568b166fb64aad2a8324088e684b16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f427b7a91ac07ffafadd88852c0dad60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7bdc0393d9ea265f3a988da9940f0df6 |
| publicationDate | 2006-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1658309-B1 |
| titleOfInvention | Peptide protein translation inhibitor and the use thereof for protein translation control |
| abstract | Peptide (I) that inhibits translation of proteins, contains at most 250 amino acids (aa) and including a sequence at least 85% identical with sequence (S1), is new. Peptide (I) that inhibits translation of proteins, contains at most 250 amino acids (aa) and including a sequence at least 85% identical with sequence (S1), is new Val-Lys-Phe-Ala-Asp-Thr-Gln-Lys-Asp-Lys-Glu-Gln-Lys-Arg-Met-Thr-Gln-Gln-Leu-(Gln) 3-Met-Gln-Gln-Leu-Asn-Ala (S1). Independent claims are also included for the following: (1) fusion protein (FP) that inhibits specifically translation of a target polynucleotide (T) comprising (I) fused to an RNA-binding protein (II); (2) nucleic acid (III) that encodes (I); (3) nucleic acid (IIIa) that encodes FP; (4) system for controlling translation of (T) comprising FP or (IIIa); (5) recombinant cloning or expression vectors that contain (III) or (IIIa); (6) prokaryotic or eukaryotic host cells that contain a system of (4), (IIIa) or a vector containing (IIIa); (7) method for in vitro control of translation of (T); and (8) kit for controlling translation of (T) that comprises FP or a vector that contains (IIIa). ACTIVITY : Virucide; Cytostatic. No details of tests for these activities are given. MECHANISM OF ACTION : Inhibition of protein translation; Gene Therapy. |
| priorityDate | 2003-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 55.